CFDA approves TaiGen antibiotic

TaiGen Biopharmaceuticals Holdings Ltd. (TPEx:4157) said China FDA approved Taigexyn nemonoxacin, a non-fluorinated quinolone antibiotic topoisomerase

Read the full 161 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE